MB, Levis & Associates’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.62M Sell
11,067
-39
-0.4% -$5.68K 0.6% 31
2026
Q1
$1.6M Buy
11,106
+882
+9% +$134K 0.67% 27
2025
Q4
$1.47M Sell
10,224
-354
-3% -$52.2K 0.62% 31
2025
Q3
$1.63M Sell
10,578
-959
-8% -$150K 0.7% 28
2025
Q2
$1.84M Sell
11,537
-46
-0.4% -$7.51K 0.81% 22
2025
Q1
$1.97M Buy
11,583
+76
+0.7% +$12.7K 0.92% 19
2024
Q4
$1.93M Sell
11,507
-5
-0% -$852 0.97% 19
2024
Q3
$1.99M Buy
11,512
+23
+0.2% +$3.9K 0.98% 18
2024
Q2
$1.89M Buy
11,489
+55
+0.5% +$8.99K 1% 18
2024
Q1
$1.86M Buy
11,434
+44
+0.4% +$6.9K 1% 19
2023
Q4
$1.67M Buy
11,390
+32
+0.3% +$4.74K 0.96% 21
2023
Q3
$1.66M Buy
11,358
+17
+0.1% +$2.6K 1.07% 18
2023
Q2
$1.72M Buy
11,341
+31
+0.3% +$4.67K 1.1% 19
2023
Q1
$1.68M Buy
11,310
+407
+4% +$58.2K 1.17% 19
2022
Q4
$1.65M Buy
+10,903
New +$1.53M 1.29% 18

Other funds holding PG

MB, Levis & Associates's PG Position: Q2 2026 in Review

MB, Levis & Associates reduced its Procter & Gamble (PG) stake by 0.35% in Q2 2026, selling an estimated $5.68K and leaving 11,067 shares worth $1.62M. The position accounts for 0.6% of the portfolio, ranked #31.

MB, Levis & Associates first reported a position in PG in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.99M in Q3 2024. 4,006 funds tracked by Wall St. Rank hold PG as of Q2 2026.

  • MB, Levis & Associates held 11,067 shares of Procter & Gamble worth $1.62M as of Q2 2026.
  • MB, Levis & Associates sold 39 Procter & Gamble shares in Q2 2026, an estimated $5.68K.
  • Procter & Gamble made up 0.6% of MB, Levis & Associates's portfolio in Q2 2026, its #31 holding.
  • MB, Levis & Associates first reported a position in Procter & Gamble in Q4 2022 and has held it in 15 quarters since.
  • MB, Levis & Associates's Procter & Gamble position peaked at $1.99M in Q3 2024.
  • 4,006 funds tracked by Wall St. Rank held Procter & Gamble as of Q2 2026.

Based on MB, Levis & Associates's 13F filing for Q2 2026, filed 22 Jul 2026.